Two Sigma Advisers’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $197K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $26K | Sell |
|
|||||
|
2022
Q3 | $34K | Sell |
|
|||||
|
2022
Q2 | $51K | Sell |
|
|||||
|
2022
Q1 | $108K | Sell |
|
|||||
|
2021
Q4 | $151K | Sell |
|
|||||
|
2021
Q3 | $363K | Sell |
|
|||||
|
2021
Q2 | $1.3M | Buy |
|
|||||
|
2021
Q1 | $1.28M | Sell |
|
|||||
|
2020
Q4 | $1.37M | Buy |
|
|||||
|
2020
Q3 | $965K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $70K | Buy |
|
|||||
|
2019
Q4 | $80K | Buy |
|